Vanda Pharmaceuticals
VNDA
$4.80
Share price
3.90%
Change (1 day)
-21.82%
Change (1 year)
Categories
Vanda Pharmaceuticals (VNDA) - Total debt
Total debt on the balance sheet as of December 2023 : $9.4 M
According to Vanda Pharmaceuticals's latest financial reports the company's total debt is $9.4 M. A company’s total debt is the sum of all current and non-current debts.
Vanda Pharmaceuticals - Total debt on balance sheet (from 2005 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $9.4 M | -15.59% |
| 2022-12-31 | $11.14 M | -9.91% |
| 2021-12-31 | $12.36 M | -9.17% |
| 2020-12-31 | $13.61 M | -6.77% |
| 2019-12-31 | $14.6 M | |
| 2018-12-31 | $N/A | |
| 2005-12-31 | $0.14 M | -61.15% |
| 2004-12-31 | $0.36 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 311,809.83% | 🇺🇸 USA |
 Novartis NVS | $27.28 B | 290,031.86% | 🇨🇭 Switzerland |
 Pfizer PFE | $70.84 B | 753,249.64% | 🇺🇸 USA |
 Eli Lilly LLY | $25.22 B | 268,140.11% | 🇺🇸 USA |
 Merck MRK | $35.05 B | 372,666.91% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $57.40 B | 610,374.27% | 🇺🇸 USA |
 Titan Pharmaceuticals
TTNP | $0.56 M | -93.99% | 🇺🇸 USA |